Jerzy Trojnar
8Patents
5h-index
16Co-inventors
56Inventor score
Filing activity: Dec 15, 1983 → Aug 2, 1999
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5965701A | Kappa receptor opioid peptides | Human Necessities | 63 | Expired |
| US6143722A | Heptapeptide oxytocin analogues | Human Necessities | 53 | Expired |
| US5698516A | Biologically active vasopressin analogues | Emerging Cross-Sectional Technologies | 36 | Expired |
| US5037957A | Cysteine proteinase inhibitor | Emerging Cross-Sectional Technologies | 26 | Expired |
| US5981170A | Peptides, artificial antigens and immunoassay kits | Chemistry; Metallurgy | 8 | Expired |
| US5459236A | Vasoactive vasotocin derivatives | Human Necessities | 5 | Expired |
| US4504469A | Vasotocin derivatives | Emerging Cross-Sectional Technologies | 4 | Expired |
| US5716779A | Diagnostic antigen and a method of in vitro diagnosing an active infection caused by hepatitis C virus | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.